Market Place
Sourcing Support
jCyte Outlines Plans to Start Trial of jCell® for Retinitis Pigmentosa
21 Feb 2024 //
BUSINESSWIRE
Center for Breakthrough Medicines and jCyte Ink Manufacturing Deal
29 Sep 2022 //
CONTRACTPHARMA
CBM & jCyte Announce Partnership to Manufacture jCyte`s Innovative Cell Therapy
20 Sep 2022 //
PRNEWSWIRE
jCyte Announces Appointment of Dr. Stewart Craig as Chief Technology Officer
12 Jul 2022 //
BUSINESSWIRE
jCyte Announces Expansion of Role for Chief Commercial Officer Samir Mody
14 Oct 2021 //
BUSINESSWIRE
jCyte Appoints R. Heath Coats as VP of CMC, Regulatory and Quality Control
06 Oct 2021 //
BUSINESSWIRE
jCyte Announces Appointment of Victor Chao as Vice President of CMC Operations
09 Sep 2021 //
BUSINESSWIRE
jCyte Inc. Announces Presentations at the 2021 Association
22 Apr 2021 //
BUSINESSWIRE
jCyte Announces Presentation of Phase 2b Results Evaluating jCell
07 Jul 2020 //
BUSINESSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.